NIAID
Dr. Jonah Odim will discuss current funding opportunities for basic and clinical research from the National Institute of Allergy and Infectious Diseases. He will also take questions on grant processes and research opportunities.
NIH Corner: NCI
Dr. Read-Connole will discuss current funding opportunities for basic and clinical research at the National Cancer Institute and take questions regarding the grant process and funding opportunities.
CDC/DVH
CDC’s Division of Viral Hepatitis Director Carolyn Wester will discuss the on-going work at DVH and the division’s role in the White House Hepatitis C Elimination plan.
Applying for R01 Funding
Are you interested in securing R01 funding for your research project? Discover the secrets to securing R01 funding for your research project. Join us for a dynamic Community Conversation, where we bring together a distinguished panel of experts, including
Creating Impact: How to get your research noticed
Attendees will learn how to make their journal articles stand out, to both editors and readers, in the current digital age. Topics will include how to write and structure a manuscript, value-added components such as videos and infographics, and how to get
How to Amplify Advocacy to Achieve Viral Hepatitis Elimination (i.e., Call to Action!)
To briefly introduce and review where we are in the elimination cascade in North America and Globally and how to achieve 2030 goals. Invited Speakers will provide their perspective on advocacy and specifically address how to increase community/general pu
Applying for Fellowship: What You Need to Know
Applying for fellowship? This program will help you find the right program, make your ERAS CV stand out from the crowd, ace the interview, and what to do if you don't match.
Mandates and best practices for liver transplant in alcohol-associated liver disease: is it time for regulation and national policy reform?
Alcohol-associated liver disease (ALD) has surged as an indication for transplant, increasing over 5-fold in the past 20 years, and is now the #1 indication for transplant in the US. Early (i.e. without mandated period of abstinence) transplant has partly
Experts' Perspectives on Challenges and Strategies for the Future of the Alcohol-associated Liver Disease (ALD) Field
This session will bring together leading experts in the field of Alcohol-associated Liver Disease (ALD) to discuss the challenges and strategies for the future of this field. ALD remains a significant public health concern, with a rising prevalence and a
Liver Transplant for Sexual and Gender Minorities
The sexual and gender minorities (SGM) people faced not only health but also psychosocial, economic, and legal disparities in accessing and receiving healthcare in general. Although specific data on liver transplants is limited, we believe such disparity